<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01458938</url>
  </required_header>
  <id_info>
    <org_study_id>Substance P</org_study_id>
    <nct_id>NCT01458938</nct_id>
  </id_info>
  <brief_title>This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid.</brief_title>
  <acronym>Substance P</acronym>
  <official_title>Substance P Neuropeptide Levels in Saliva, Serum and Cerebrospinal Fluid in Patients With Spinal Disease: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carolina Neurosurgery &amp; Spine Associates</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carolina Neurosurgery &amp; Spine Associates</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this pilot study is to determine if degenerative spinal disorders such as
      acute radiculopathy, myelopathy, stenosis, or disc and facet disease cause detectable
      alterations in Substance P levels in saliva, serum and cerebrospinal fluid. If this pilot
      study shows a correlation between Substance P levels and pain associated with degenerative
      spinal disorders, then a larger study will be initiated to determine the feasibility of using
      Substance P levels in the diagnosis and treatment of degenerative spinal disease.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study will need to be redesigned for improved efficacy.
  </why_stopped>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Substance P Neuropeptide Levels in Saliva And Serum in Patients with Spinal Disease: A Pilot Study</measure>
    <time_frame>2009-2014</time_frame>
    <description>Study was closed pending re-design at some future date to improve efficacy.</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">53</enrollment>
  <condition>Spinal Disease</condition>
  <condition>Spinal Radiculopathy</condition>
  <condition>Myelopathy</condition>
  <condition>Neurogenic Claudication</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>surgery for spinal radiculopathy</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>surgery for axial spine pain</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>myelography for spinal pain</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>treatment plan</intervention_name>
    <description>Data Collection Study</description>
    <arm_group_label>surgery for spinal radiculopathy</arm_group_label>
    <arm_group_label>surgery for axial spine pain</arm_group_label>
    <arm_group_label>myelography for spinal pain</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, saliva and cerebrospinal fluid
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing spinal surgery for medically refractory spinal radiculopathy,

          -  myelopathy or neurogenic claudication based on either history, physical examination or
             radiologic studies demonstrating neural compression or degenerative disc disease.

          -  Undergoing surgery for medically refractory axial spinal pain.

        Exclusion Criteria:

          -  Previous spinal procedures or operations,

          -  radicular pain,

          -  history of fibromyalgia,

          -  chronic pain,

          -  rheumatoid arthritis,

          -  autoimmune disorders,

          -  HIV,

          -  PTSD,

          -  Major Depressive Disorder,

          -  migraine headaches or active rhinosinusitis,

          -  nicotine intake
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vinay Deshmukh, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carolina Neurosurgery &amp; Spine Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Carolina Neurosurgery and Spine Associates, P.A.</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2011</study_first_submitted>
  <study_first_submitted_qc>October 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2011</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Radiculopathy</mesh_term>
    <mesh_term>Spinal Cord Diseases</mesh_term>
    <mesh_term>Spinal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance P</mesh_term>
    <mesh_term>Neurokinin A</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

